Press Releases Finch Therapeutics Group, Inc.

Equities

FNCH

US31773D2009

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
2.12 ^USD	-2.75%		-8.20%	-41.27%

Mar. 25	Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 12	Top Premarket Decliners	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)	23-10-27	AQ
FINCH THERAPEUTICS GROUP, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23-06-09	AQ
Finch Announces Reverse Stock Split of Common Stock	23-06-09	GL
Finch Announces Reverse Stock Split of Common Stock	23-06-09	AQ
FINCH THERAPEUTICS GROUP, INC. : Change in Directors or Principal Officers (form 8-K)	23-05-30	AQ
FINCH THERAPEUTICS GROUP, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-05-18	AQ
FINCH THERAPEUTICS GROUP, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-10	AQ
Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates	23-05-10	GL
FINCH THERAPEUTICS GROUP, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-25	AQ
Finch Therapeutics Announces Executive Leadership Transitions	23-04-25	GL
Finch Therapeutics Announces Executive Leadership Transitions	23-04-25	AQ
FINCH THERAPEUTICS GROUP, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-18	AQ
Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License Agreement	23-04-18	GL
FINCH THERAPEUTICS GROUP, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-23	AQ
Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates	23-03-23	GL
Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates	23-03-23	AQ
In The Queue: AcurX Pharmaceuticals Earnings...Here's What Investors Need To Know Before Thursday ($ACXP)	23-03-15	AQ
Race To The Cure: Here's Why Acurx Pharmaceuticals Could Win The Battle To Treat C. difficile ($ACXP)	23-02-21	AQ
Acurx Pharmaceuticals CEO Is Confident His Ibezapolstat Can Earn Front-Line Designation To Treat C. difficile...Here's Why ($ACXP)	23-02-08	AQ
Finch Therapeutics : Termination of Material Agreement - Form 8-K	23-01-26	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Finch Therapeutics Group, Inc.

Equities

FNCH

US31773D2009

Press Releases

Filters